RxDoctor Payments Data

Larry Reece, APRN

Family · Glasgow, KYNPI 1801559588

Payments from drug & device makers

$1,037in general payments, 2019–2025

Across 65 payments — averaging $15.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$357
  • Pfizer$188
  • Amgen$156
  • AstraZeneca$100
  • Merck$74
  • Johnson & Johnson$27
  • plus $135 from 8 others

What the payments were for

  • Food & beverage$93790%
  • Education$10010%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,037 in reported general payments places this provider in the 65th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$4,266
Medicare patients
42
Services billed
393

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban250$203,504
XareltoRivaroxaban35$35,709
EntrestoSacubitril/Valsartan31$34,880
VascepaIcosapent Ethyl71$30,523
Ranolazine ErRanolazine268$21,804
BrilintaTicagrelor28$20,714
Praluent PenAlirocumab26$12,932
Repatha SureclickEvolocumab21$11,634
Prasugrel Hcl67$9,464
Amiodarone Hcl77$3,371
Enoxaparin Sodium20$2,913
Metoprolol Succinate233$2,385
Potassium Chloride139$2,174
Midodrine Hcl28$1,332
Atorvastatin Calcium236$1,307

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$188$203,504250 claims
Johnson & JohnsonXarelto$27$35,70935 claims
AstraZenecaBrilinta$100$20,71428 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 4,374 family providers in Kentucky.

Other family in Glasgow

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →